Search filters

List of works by Dinesh Khanna

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

scientific article

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

scientific article published in October 2012

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

scientific article

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

scientific article

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

scientific article published on 06 August 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

scientific article published on 05 August 2019

2020 American College of Rheumatology Guideline for the Management of Gout

scientific article published on 10 May 2020

2020 American College of Rheumatology Guideline for the Management of Gout

scientific article published on 11 May 2020

A Multi-Centre Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis

scientific article published on 16 December 2019

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria

scientific article published on 15 February 2013

A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis

scientific article published on 22 September 2020

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

scientific article published on 10 December 2019

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

scientific article

Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study

scientific article

Cardiac arrhythmias and conduction defects in systemic sclerosis

scientific article

Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry

scientific article published on 4 April 2016

Clinical Phenotypes of Patients with Systemic Sclerosis with Distinct Molecular Signatures in Skin

scientific article published in 2022

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

scientific article

Current and future outlook on disease modification and defining low disease activity in systemic sclerosis

scientific article published on 05 March 2020

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

scientific article published on 28 September 2015

Dissecting the cellular mechanism of prostacyclin analogue iloprost in reversing vascular dysfunction in scleroderma

scientific article published on 01 October 2020

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

scientific article

Fatigue and its Association with Social Participation, Functioning and Quality of Life in Systemic Sclerosis

scientific article published on 16 December 2019

Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile

scientific article published on 25 November 2019

Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

scientific article published on January 2014

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

scientific article published on March 2012

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

scientific article published on 09 June 2017

Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts

scientific article

Management of systemic sclerosis-associated interstitial lung disease in the current era

scientific article published on 01 February 2020

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

scientific article published on 16 January 2019

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria

scientific article

New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis

scientific article published on 30 November 2020

Outcome evaluations in gout

scientific article published in June 2007

Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis

scientific article published on 25 June 2020

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

scientific article published on 14 August 2020

Predictive Significance of Serum Interferon Inducible Protein Score for Response to Treatment in Systemic Sclerosis Related Interstitial Lung Disease

scientific article published on 21 December 2020

Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18

scientific article published on 01 November 2019

Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II

scientific article published on 05 December 2020

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

scientific article

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

scientific article published on 15 July 2020

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

scientific article published on 01 May 2020

Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design

scientific article published on May 1, 2010

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

scientific article published on 29 April 2020

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

scientific article

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

scientific article published on 20 May 2020

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

scientific article

Update of EULAR recommendations for the treatment of systemic sclerosis

scientific article published on 9 November 2016

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria

scientific article published on 15 December 2018

Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease

scientific article published on 26 December 2019